Established August 2000
Canadian Non Profit, Non Share Corporation
Date of Letters Patent - January 15, 2001
Board of Directors:
July 1, 2010 to June 30, 2013
- Laurence Klotz, MD - Chairman
Directors:
- Dr. Joseph Chin
- Dr. John Grantmyre
- Dr. Alan So
- Dr. Anil Kapoor
- Dr. Sender Herschorn
Directors at Large:
Ex-Officio Board Members:
Credentials Committee:
- Dr. Chris W. B. Jensen
- Dr. Gary Steinhoff
Scientific Committee:
(TBA)
Management Consultant:
Executive Assistant:
Irene McNeill
Membership:
Over 120 urologists
Clinical Trial Sites:
Over 80
Sources of Funding:
- Client Sponsor Agreements
Cooperative Alliances:
- Canadian Urology Association
- Canadian Uro-Oncolgy Group
General Liability Insurance:
- Health Insurance Reciprocal of Canada (HIROC)
Auditors:
Campbell Lawless Chartered Accountants
Legal Counsel:
Enfield Adair Wood & McEwan
CURC CLIENTS:
- Abbott Laboratories Limited
- Astra Zeneca Canada Inc.
- CMX Research Inc.
- Dendreon Corporation
- Ferring Inc.
- GlaxoSmithKline
- Merck Frosst Canada Ltd.
- Sanofi - Synthelabo Canada Inc.
- Spectrum Pharmaceuticals Inc.
- Viventia Biotech Inc.